LUGOLABS
A South Korean FFF 3D printer manufacturer specializing in professional desktop and industrial-grade systems with proprietary dual extrusion and multi-head toolchanging technologies, recently expanded into medical/dental applications with human tissue-mimicking filaments.
- CEO / Founder
- Jihun Kang
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- $67K
- Latest Round
- Crowdfunding
- Key Investors
- 80 crowdfunding backers
Technology & Products
Key Products
LUGO G3 Professional dual extruder 3D printer (DCH head); LUGO G3 HT High-temperature version; LUGO G3 S Food-grade version
Technological Advantage
Combines three patented/patent-pending innovations: (1) DCH-head for efficient dual extrusion without calibration complexity, (2) Multi-head toolchanging system (Patent W02025244395) for waste-free multi-material printing, and (3) Tissue-equivalent filaments for medical phantom applications. All systems feature integrated filament drying and H13 carbon-HEPA filtration, eliminating need for external equipment. Open material system provides maximum flexibility.
Differentiation
Value Proposition
Delivers professional-grade FFF 3D printing with patented innovations that eliminate dual-extrusion calibration challenges, integrated filament drying and air filtration systems, and the unique ability to produce medical phantoms with human tissue-equivalent radiodensity for CT/X-ray imaging applications.
How They Differentiate
LUGOLABS differentiates through three patented technologies: (1) DCH (Dual Cone-shaped Head) that eliminates dual-extrusion calibration requirements while enabling independent temperature control, (2) world's first six-head toolchanging FFF printer (LUGO H1) with patent W02025244395 for hot-end swapping, and (3) proprietary medical-grade filaments (Lugofil line) that accurately mimic human bone, skin, and tissue radiodensity for CT/X-ray imaging applications. All systems feature integrated filament drying and H13 carbon-HEPA filtration. Unlike competitors who focus solely on industrial/prosumer markets, LUGOLABS has expanded into medical imaging with tissue-equivalent materials.
Market & Competition
Target Customers
Professional engineers, industrial manufacturers, dental/medical professionals, medical imaging specialists, research institutions, and educational facilities requiring multi-material or medical-grade 3D printing capabilities
Industry Verticals
Additive Manufacturing / 3D Printing Hardware, Industrial Manufacturing, Medical Devices, Dental Technology, Medical Imaging & Diagnostics, Healthcare Education & Research
Competitors
Raise3D; UltiMaker (Ultimaker); Prusa Research; BCN3D
Growth & Milestones
Growth Metrics
Bootstrapped/self-funded company with primary public funding through Kickstarter campaign. Successfully raised $66,632 from 80 backers (133% of $50,000 goal) with average pledge of $833 per backer. Transitioned from domestic Korean manufacturer (Formers Farm brand) to international LUGOLABS brand with active global sales through online retailers and trade show presence.
Major Milestones
Company founded in 2013 as Formers Farm (domestic Korean 3D printer manufacturer), Business registration established January 27, 2014 (Registration: 609-86-17243), Successful Kickstarter campaign for LUGO G3 raising $66,632 (March-April 2022), Launched LUGO G3 HT high-temperature professional dual extruder printer, Introduced LUGO H1 industrial six-head toolchanging 3D printer (2024), Developed proprietary medical-grade filaments (Lugofil) mimicking human tissue radiodensity (December 2024), Awarded Patent W02025244395 for Multi-Output-Head Module (2025), International trade show exhibitions at Formnext (2023, 2024) and De Medica 2024, Rebranded from Formers Farm to LUGOLABS for global market expansion
Notable Customers
Medical imaging professionals (via MedicalExpo partnership); Industrial manufacturers (via Top3DShop distribution); Dental professionals; Research institutions